Viking Therapeutics, Inc. (NASDAQ:VKTX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 11, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
Viking Therapeutics, Inc.'s stock currently trades at $28.55 with a market capitalization of $4.2B.